Wednesday, January 30, 2013

WADA calls UCI 'deceitful' in doping probe

LONDON (AP) ? The World Anti-Doping Agency called the UCI "deceitful" Tuesday for shutting down its independent doping panel and said it won't participate in an amnesty commission set up by the cycling governing body.

WADA said the UCI has "again chosen to ignore its responsibility to the sport" by disbanding the panel looking into claims that cycling leaders helped cover up Lance Armstrong's suspicious doping tests and accepted $125,000 from him in donations.

Instead, the UCI announced Monday plans to set up a separate amnesty-style "truth and reconciliation commission" that it claimed was supported by WADA President John Fahey.

"This is not only wrong in content and process, but again deceitful," WADA said in a statement. "The fact is that WADA was awaiting a reply to the correspondence when the UCI release was delivered.

"WADA has not and will not consider partaking in any venture with UCI while this unilateral and arrogant attitude continues."

The anti-doping agency added that it will not "pay for or contribute to any collaborative effort with UCI into investigating UCI's long-standing problems with doping in its sport and its alleged complicity."

Accusations against the UCI emerged in the U.S. Anti-Doping Agency report that detailed doping and led to Armstrong being stripped of his seven Tour de France titles. Armstrong recently confessed to doping after years of denials.

In justifying the reason to disband the independent panel, the UCI cited WADA's refusal to cooperate with the inquiry.

But WADA on Tuesday said it would not participate because of the "inadequacies of the terms of reference and the timelines." It also didn't want the UCI to scrutinize or edit the findings before they were released.

WADA said it hopes the UCI's independent commission will still meet as previously planned on Thursday, despite being disbanded. The three-person body said Tuesday the UCI never provided the cooperation ? promised by UCI President Pat McQuaid ? to allow it to function.

"This failure to cooperate makes our task impossible," the commission, which was chaired by British judge Philip Otton, said in a statement. "Therefore, the proposed hearing on (Jan. 31) will not take place."

Source: http://news.yahoo.com/wada-calls-uci-deceitful-doping-probe-155901435--spt.html

tulsa easter eggs pineapple upside down cake free ecards flying car masters golf tournament the replacements

Tuesday, January 29, 2013

Nicholas Hoult Warm Bodies Interview

"Warm Bodies" is the first zombie movie told from the point of view of the zombie himself -- and, as played by Nicholas Hoult, he's surprisingly charming. Here, Hoult (Hank McCoy, aka Beast, in "X-Men: First Class") stars as "R.," the Romeo-esque undead lead character who can't remember his full name. However, he does remember (barely) what it was like to be human when he meets Julie (Teresa Palmer) and decides to protect her rather than eat her brains. What follows is a very unlikely romance that changes the status quo for both zombies and humans.

Hoult spoke to Moviefone about his zombie makeover, fake brains and the hardest part about playing someone who's supposed to be undead.

What was your first reaction when someone approached you to star in a zombie romantic comedy?
No one really said much about the concept of it. I'd heard some good things and I saw that it was adapted by Jonathan Levine, and he was going to direct it. I was a fan of his already, so I thought it was probably going to be something interesting. And then I started reading it and just really enjoyed it. It was funny and sweet and the character was just something that I really wanted to play.

What was your inspiration for your zombie walk?
We kind of did a bit of zombie schooling. It was more a feeling of just being really tired.
Stumbling around a little bit and just a slight lack of coordination. We watched a lot of zombie films in the build-up just to kind of get an idea of what had been done before. We didn't want to get too over-the-top and ridiculous. We wanted something more subtle.

What's your favorite zombie movie?
I do really like "Shaun of the Dead" and "Zombieland." But "28 Days Later" is great as well.

Do you think a zombie romance is a tough sell for audiences?
At first, you have some internal voiceover and you realize that before he was undead, but this is quite a witty guy with a dry sense of humor that, hopefully, has a charm to him. So I think it's more about people to like that side of his personality than how he looks.

What was the toughest part of playing a zombie?
Not laughing, actually, is really difficult, particularly doing scenes with Rob Corddry.
We'd literally do scenes where there was nothing scripted, it was just me and him grunting and kind of having a conversation. One of us would do a weird grunt and then we'd both start cracking up.

You get probably the first zombie makeover in movie history.
Yeah, that was also a difficult scene not to laugh throughout. Slapping the makeup on me, yeah.

Do you think horror purists will enjoy it?
That's a tricky one because people get quite possessive of the zombie characters and feel as though they shouldn't think and all they should do is hunt and that's it. Once people see it and see the humor in it and let go of that a little bit, I think they can enjoy it. I think they'll be entertained.

What were the "brains" you're seen eating?
They were a kind of wet, peachy sponge thing with grapefruit and stuff. It was an odd taste. Nothing that I'd recommend.

What's going on with the "X-Men: First Class" sequel?
I think we start shooting later on this year. I haven't read anything yet but I've heard it's a really cool script. They're still working on it a little bit, but I think it's going to be very exciting.

Beast has gone through a major transformation: Does that mean we won't be seeing you onscreen anymore in your non-mutated form?
Well, wait and see on that.

What do you hope happens in the sequel?
I'm dying to find out more. I know they've got some cool stuff planned. It was a character I really enjoyed playing. I'm just looking forward to being with those actors again and with Bryan Singer directing as well. I did a film with recently him, "Jack the Giant Slayer," so it'll be nice to work with him again.

Do you still have people telling you how much they loved you in "About a Boy?"
Sometimes, yeah. Earlier on today, there was a nice lady I met who was a really big fan of it. It's great that people still hold that film dear in their hearts. I'm very proud of it. The Weitz brothers are some of the nicest people to work with and great directors. I was fortunate to work with them and learn from them.

So now you've played a mutant and a zombie... what's next?
Next, I suppose, I'm in "Mad Max." I'm playing a warrior driver character. It was a lot of fun and a very cool movie to be a part of. Just the vehicles they built and the story and the action. George Miller, the director, is a top guy so I had a lot of fun working for him.

"; var coords = [-5, -72]; // display fb-bubble FloatingPrompt.embed(this, html, undefined, 'top', {fp_intersects:1, timeout_remove:2000,ignore_arrow: true, width:236, add_xy:coords, class_name: 'clear-overlay'}); });

Source: http://www.rottentomatoes.com/m/1926745/news/1926745/

mariners mets shades of grey pittsburgh penguins record store day jennie garth space needle

India cuts rates after 9-month wait, RBI stays cautious

MUMBAI (Reuters) - India's central bank lowered its key policy rate as expected for the first time in nine months to support an economy set for its slowest growth in a decade, but signaled there was less room for aggressive cuts in future due to concerns over inflation.

The Reserve Bank of India cut the policy repo rate by 25 basis points to 7.75 percent, in line with a Reuters poll earlier this month.

The RBI unexpectedly also reduced the cash reserve ratio (CRR), the share of deposits banks must keep with the central bank by 25 bps to 4.00 percent, which will infuse an additional 180 billion rupees into the banking system.

India's headline inflation rate moderated to a three-year low of 7.18 percent in December, and the central bank said there was likelihood that inflation would remain rangebound around current levels heading into 2013/14 fiscal year starting April.

"This provides space, albeit limited, for monetary policy to give greater emphasis to growth risks," the central bank said in its quarterly monetary policy review.

Bond and stock markets were largely unmoved as dealers had already priced in a quarter percentage point rate cut. The 10-year bond yield was flat at around 7.87 percent. India's main NSE index <.nsei> was also flat, with the bank sub-index <.nsebank> up 0.2 percent, paring initial stronger gains.

The Indian rupee strengthened to 53.79 to the dollar from around 53.84 before the decision.

"RBI has not abandoned its cautious stance, stressing on the 'calibrated and limited' nature of rate support (from) hereon," said Radhika Rao, economist, Forecast Pte in Singapore.

"The scale of rate cuts is closely tied to the government's sustained efforts to correct the twin imbalances and moderating inflation trajectory."

The central bank however reiterated its concerns over a bloated fiscal and current account deficits (CAD) adding that its pro-growth stance will be conditioned by the management of the risks posed by them.

"Financing the CAD with increasingly risky and volatile flows increases the economy's vulnerability to sudden shifts in risk appetite and liquidity preference, potentially threatening macroeconomic and exchange rate stability," the RBI said.

Since a 50 basis point cut in April, the central bank had kept interest rates on hold as inflation stayed stubbornly high, ignoring repeated calls from the government for a cut.

Having grown at near-double-digit pace before the Lehman Brothers crisis, the economy has suffered a rapid deceleration.

The RBI cut its GDP growth forecast for Asia's third-largest economy to 5.5 percent for the current fiscal year, from 5.8 percent previously, and lowered its projection for headline inflation in March to 6.8 percent from 7.5 percent earlier.

(Additional reporting by Mumbai treasury team; Editing by Simon Cameron-Moore)

Source: http://news.yahoo.com/indias-central-bank-cuts-policy-rate-25-bps-054334509--business.html

aubrey o day masters live johan santana viktor bout ncaa hockey role models ferdinand porsche

Student Recreation | InnerVU | Vanderbilt University

Vanderbilt Recreation Center ? Twenty Third Anniversary

Intramural Registration
Registrations can be completed at the Office of Campus Recreation from 9 am ? 5 pm Mon. ? Fri. Each house?s vice president will be responsible for assisting the Office of Campus Recreation in promoting and registering teams for both the Commons sporting events and intramural sports. For more info call 3-8186.

Men?s & Women?s Programs Entry Date?Start Date
Badminton?????????????????????????????????????????? Jan. 28 ? Feb 1 ? ? ? ? ? Feb. 9
Bowling ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Feb 4 ? 8 ? ? ? ? ? ? ? ? ? ?Feb 16
Soccer ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?Feb 25 ? Mar 1 ? ? ? ? ? ? Mar 17

Co-Rec Programs Entry Date?Start Date
Soccer ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Feb 25 ? Mar 1 ? ? ? ? ? ? Mar 17
Ultimate Frisbee????????????????????????????????? Mar 11 ? 15???????????????? Mar 24

For a complete calendar of activities for the 2013 Spring semester, ?please check out our website at?http://www.vanderbilt.edu/studentrec/intramurals/calendar/.

Smoothie King is now open in the Vanderbilt Student Recreation Center.

Work on the Natchez Field has begun. This renovation will create two softball fields. The spring 2013 softball season will be played at this location.

The expansion on the southwest corner of the Rec is well underway. This area will host more fitness room space and
multi-purpose rooms.

Foundations are nearing completion. Steel for the project will be arriving in the next few weeks.

To see aerial shots provided by Aerial Innovations of TN and to see our progress, go tohttp://www.vanderbilt.edu/studentrec/facilities-improvement-for-you/.

Now hiring?Swim Instructors?and?Lifeguards?for Spring / Summer 2013.

Swim Instructors: Swim Instructors are needed for both private and group lessons. Previous experience required.

Lifeguards: Lifeguards are needed for recreational swimming, lap swimming and OCR programs. Duties include opening and closing pool, enforcing pool rules and swimmer safety. Each lifeguard must possess a current lifeguard and CPR-professional rescuer certifications.

Pay is $8.00 per hour

Please contact:?kit.wilson@vanderbilt.edu


CPR/First Aid Classes @ The Rec

Sunday, February 3rd, 2013, 4 ? 9 pm
Sunday, February 17th, 2013, 4 ? 9 pm
Sunday, March 10th 2013, 4 ? 9 pm

Sign up in the Office of Campus Recreation.

Registration

Be sure to register as soon as possible. Class size is limited to 15 participants based on first come, first served and will fill up quickly!

Cost: $120 (Payment is due at the time of registration. Please make checks payable to Vanderbilt University.)

To register, stop by the Office of Campus Recreation during office hours, Monday-Friday 9am-5pm. For more information, email?kate.vanlandingham@vanderbilt.edu or call 343-8186.?No Phone Reservations.

Classes are held in Classroom A & B of the Student Recreation Center.

Group Fitness Classes This Week

For Aerobics & Yoga Class Descriptions, please got to our website athttp://www.vanderbilt.edu/studentrec/fitness/group-fitness/.

Mondays

11:30 ? 12:30 pm?YOGA with Polly
4:00 ? 5:00 pm?HIP HOP CARDIO with Kimberly
5:00 ? 6:00 pm?ZUMBA with Carney
6:15 ? 6:30 pm?HARD@AA with Alyson
6:30 ? 7:00 pm?HARDCORE with Alyson
7:00 ? 8:00 pm?SPIN with Johnny

Tuesdays

6:00 ? 6:45 am?SPIN EXPRESS with Lindey
10:00 ? 11:00 am?CARDIO BLAST with Jennifer
1:00 ? 1:30 pm?CARDIO EXPRESS with Kimberly
3:00 ? 4:00 pm?HARDBODY with Alyson
4:00 ? 5:00 pm?BOOT CAMP with Johnny (meets @ Front Desk)
4:30 ? 5:30 pm?BEGINNER YOGA with Stephen
5:30 ? 6:30?YOGA with Stephen

Wednesdays

6:00 ? 7:00 am??PILATES with Stefanie
7:00 ? 8:00 am?30/20/10 with Kimberly
11:30 ? 12:30 pm ?YOGA with Polly
4:30 ? 5:30 pm??ZUMBA with Carney
5:30 ? 6:30 pm??MEDITATION CLASS with Natalie (meets in classroom A)
5:30 ? 6:30 pm??KICKBOXING with Madeleine
6:30 ? 7:00 pm?HARDCORE with Alyson
7:00 ? 8:00 pm??SPIN with Johnny

Thursday

6:00 ? 6:45 am?SPIN EXPRESS with Lindey
7:00 ? 8:00 am?YOGA with Polly
4:00 ? 5:00 pm?BOOT CAMP with Johnny (meets @ Front Desk)
5:00 ? 5:30 pm?ZUMBA EXPRESS with Hannah
5:30 ? 6:30 pm ?YOGA with Stephen
6:00 ? 7:00 pm?AQUA BOOT CAMP with Kathryn (meets at pool)

Friday

10:00 ? 11:00 am?CARDIO BLAST with Jennifer
3:30 ? 4:30 pm ZUMBA with Carney
4:30 ? 5:30?SPIN with Alyson
5:30 ? 6:30 pm ??BODY BURN with Madeleine

Saturday

10:15 ? 11:15 am ? YOGA with Polly

Sunday

12:30 ? 1:30 pm ?SPIN with Johnny
2:00 ? 3:00 pm?STEP N CORE with Kathryn
3:00 ? 4:00 pm?TURBOKICK with Kathryn
4:00 ? 4:30 pm?AWESOME ABS with Kathryn
4:30 ? 5:30 pm?ZUMBA with Hannah
5:30 ? 6:30 pm?CARDIO CIRCUIT with Carney
6:30 ? 7:30 pm?30/20/10 with Kimberly

Recreation Facility Hours:
Mon.- Thu ?????? 5:30 am ? 11 pm
Fri ?????????????????? 5:30 am ? 12 am
Sat?????????????????? 9 am ? 10 pm
Sun????????????????? 12 pm? ? 11 pm
Visit our website at?http://www.vanderbilt.edu/studentrec/

?



Source: http://www.vanderbilt.edu/innervu/news/student-recreation-27

argentina train crash nancy pelosi nancy pelosi gop debate republican debate lewis black kirkwood

Neuroscientists pinpoint location of fear memory in amygdala

Jan. 27, 2013 ? A rustle of undergrowth in the outback: it's a sound that might make an animal or person stop sharply and be still, in the anticipation of a predator. That "freezing" is part of the fear response, a reaction to a stimulus in the environment and part of the brain's determination of whether to be afraid of it.

A neuroscience group at Cold Spring Harbor Laboratory (CSHL) led by Assistant Professor Bo Li Ph.D., together with collaborator Professor Z. Josh Huang Ph.D., have just released the results of a new study that examines the how fear responses are learned, controlled, and memorized. They show that a particular class of neurons in a subdivision of the amygdala plays an active role in these processes.

Locating fear memory in the amygdala

Previous research had indicated that structures inside the amygdalae, a pair of almond-shaped formations that sit deep within the brain and are known to be involved in emotion and reward-based behavior, may be part of the circuit that controls fear learning and memory. In particular, a region called the central amygdala, or CeA, was thought to be a passive relay for the signals relayed within this circuit.

Li's lab became interested when they observed that neurons in a region of the central amygdala called the lateral subdivision, or CeL, "lit up" in a particular strain of mice while studying this circuit.

"Neuroscientists believed that changes in the strength of the connections onto neurons in the central amygdala must occur for fear memory to be encoded," Li says, "but nobody had been able to actually show this."

This led the team to further probe into the role of these neurons in fear responses and furthermore to ask the question: If the central amygdala stores fear memory, how is that memory trace read out and translated into fear responses?

To examine the behavior of mice undergoing a fear test the team first trained them to respond in a Pavlovian manner to an auditory cue. The mice began to "freeze," a very common fear response, whenever they heard one of the sounds they had been trained to fear.

To study the particular neurons involved, and to understand them in relation to the fear-inducing auditory cue, the CSHL team used a variety of methods. One of these involved delivering a gene that encodes for a light-sensitive protein into the particular neurons Li's group wanted to look at.

By implanting a very thin fiber-optic cable directly into the area containing the photosensitive neurons, the team was able to shine colored laser light with pinpoint accuracy onto the cells, and in this manner activate them. This is a technique known as optogenetics. Any changes in the behavior of the mice in response to the laser were then monitored.

A subset of neurons in the central amygdala controls fear expression

The ability to probe genetically defined groups of neurons was vital because there are two sets of neurons important in fear-learning and memory processes. The difference between them, the team learned, was in their release of message-carrying neurotransmitters into the spaces called synapses between neurons. In one subset of neurons, neurotransmitter release was enhanced; in another it was diminished. If measurements had been taken across the total cell population in the central amygdala, neurotransmitter levels from these two distinct sets of neurons would have been averaged out, and thus would not have been detected.

Li's group found that fear conditioning induced experience-dependent changes in the release of neurotransmitters in excitatory synapses that connect with inhibitory neurons -- neurons that suppress the activity of other neurons -- in the central amygdala. These changes in the strength of neuronal connections are known as synaptic plasticity.

Particularly important in this process, the team discovered, were somatostatin-positive (SOM+) neurons. Somatostatin is a hormone that affects neurotransmitter release. Li and colleagues found that fear-memory formation was impaired when they prevent the activation of SOM+ neurons.

SOM+ neurons are necessary for recall of fear memories, the team also found. Indeed, the activity of these neurons alone proved sufficient to drive fear responses. Thus, instead of being a passive relay for the signals driving fear learning and responses in mice, the team's work demonstrates that the central amygdala is an active component, and is driven by input from the lateral amygdala, to which it is connected.

"We find that the fear memory in the central amygdala can modify the circuit in a way that translates into action -- or what we call the fear response," explains Li.

In the future Li's group will try to obtain a better understanding of how these processes may be altered in post-traumatic stress disorder (PTSD) and other disorders involving abnormal fear learning. One important goal is to develop pharmacological interventions for such disorders.

Li says more research is needed, but is hopeful that with the discovery of specific cellular markers and techniques such as optogenetics, a breakthrough can be made.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by Cold Spring Harbor Laboratory.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. Haohong Li, Mario A Penzo, Hiroki Taniguchi, Charles D Kopec, Z Josh Huang, Bo Li. Experience-dependent modification of a central amygdala fear circuit. Nature Neuroscience, 2013; DOI: 10.1038/nn.3322

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_science/~3/lxzF37HaE7w/130128104739.htm

the walking dead Walking Dead Season 3 vampire diaries derek jeter Red Bull Stratos Redbull Stratos steve mcnair

Monday, January 28, 2013

Patients' own skin cells are transformed into heart cells to create 'disease in a dish'

Patients' own skin cells are transformed into heart cells to create 'disease in a dish'

Monday, January 28, 2013

Most patients with an inherited heart condition known as arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) don't know they have a problem until they're in their early 20s. The lack of symptoms at younger ages makes it very difficult for researchers to study how ARVD/C evolves or to develop treatments. A new stem cell-based technology created by 2012 Nobel Prize winner Shinya Yamanaka, M.D., Ph.D., helps solve this problem. With this technology, researchers can generate heart muscle cells from a patient's own skin cells. However, these newly made heart cells are mostly immature. That raises questions about whether or not they can be used to mimic a disease that occurs in adulthood. In a paper published January 27 in Nature, researchers at Sanford-Burnham Medical Research Institute and Johns Hopkins University unveil the first maturation-based "disease in a dish" model for ARVD/C. The model was created using Yamanaka's technology and a new method to mimic maturity by making the cells' metabolism more like that in adult hearts. For that reason, this model is likely more relevant to human ARVD/C than other models and therefore better suited for studying the disease and testing new treatments.

"It's tough to demonstrate that a disease-in-a-dish model is clinically relevant for an adult-onset disease. But we made a key finding here?we can recapitulate the defects in this disease only when we induce adult-like metabolism. This is an important breakthrough considering that ARVD/C symptoms usually don't arise until young adulthood. Yet the stem cells we're working with are embryonic in nature," said Huei-Sheng Vincent Chen, M.D., Ph.D., associate professor at Sanford-Burnham and senior author of the study.

To establish this model, Chen teamed up with expert ARVD/C cardiologists Daniel Judge, M.D., Joseph Marine, M.D., and Hugh Calkins, M.D., at Johns Hopkins University. Johns Hopkins is home to one of the largest ARVD/C patient registries in the world.

"There is currently no treatment to prevent progression of ARVD/C, a rare disorder that preferentially affects athletes. With this new model, we hope we are now on a path to develop better therapies for this life-threatening disease," said Judge, associate professor and medical director of the Center for Inherited Heart Disease at the Johns Hopkins University School of Medicine.

Disease in a dish

To recreate a person's own unique ARVD/C in the lab, the team first obtained skin samples from ARVD/C patients with certain mutations believed to be involved in the disease. Next they performed Yamanaka's technique: adding a few molecules that dial back the developmental clock on these adult skin cells, producing embryonic-like induced pluripotent stem cells (iPSCs). The researchers then coaxed the iPSCs into producing an unlimited supply of patient-specific heart muscle cells. These heart cells were largely embryonic in nature, but carried along the original patient's genetic mutations.

However, for nearly a year, no matter what they tried, the team couldn't get their ARVD/C heart muscle cells to show any signs of the disease. Without actual signs of adult-onset ARVD/C, these young, patient-specific heart muscle cells were no use for studying the disease or testing new therapeutic drugs.

Speeding up time

Eventually, the team experienced the big "aha!" moment they'd been looking for. They discovered that metabolic maturity is the key to inducing signs of ARVD/C, an adult disease, in their embryonic-like cells. Human fetal heart muscle cells use glucose (sugar) as their primary source of energy. In contrast, adult heart muscle cells prefer using fat for energy production. So Chen's team applied several cocktails to trigger this shift to adult metabolism in their model.

After more trial and error, they discovered that metabolic malfunction is at the core of ARVD/C disease. Moreover, Chen's team tracked down the final piece of puzzle to make patient-specific heart muscle cells behave like sick ARVD/C hearts: the abnormal over-activation of a protein called PPAR?. Scientists previously attributed ARVD/C to a problem in weakened connections between heart muscle cells, which occur only in half of the ARVD/C patients. With the newly established model, they not only replicated this adult-onset disease in a dish, but also presented new potential drug targets for treating ARVD/C.

What's next?

Chen's team was recently awarded a new grant from the California Institute for Regenerative Medicine to create additional iPSC-based ARVD/C models. With more ARVD/C models, they will determine whether or not all (or at least most) patients develop the disease via the same metabolic defects discovered in this current study.

Together with the Johns Hopkins team, Chen also hopes to conduct preclinical studies to find a new therapy for this deadly heart condition.

###

Sanford-Burnham Medical Research Institute: http://www.burnham-inst.org

Thanks to Sanford-Burnham Medical Research Institute for this article.

This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.

This press release has been viewed 26 time(s).

Source: http://www.labspaces.net/126483/Patients__own_skin_cells_are_transformed_into_heart_cells__to_create__disease_in_a_dish_

richard threlkeld moonrise kingdom coachella lineup joran van der sloot coachella 2012 lineup school delays critics choice awards 2012

S&P 500 slips after rally, but Apple lifts Nasdaq

NEW YORK (Reuters) - The S&P 500 edged lower on Monday as a four-week rally stalled, while a rebound in Apple shares helped buoy the Nasdaq.

Caterpillar shares helped cap losses in the Dow industrials even as the company posted a 55 percent drop in quarterly profit due to a charge connected with accounting fraud at a Chinese subsidiary and weak demand among its dealers. Caterpillar's shares, down 2.2 percent in the past three sessions, rose 1.5 percent Monday to $96.97.

The S&P 500 is coming off a streak of eight sessions of gains, the longest in eight years. On Friday, the major U.S. stock indexes closed a fourth straight week of gains with the S&P 500 ending the session above 1,500 for the first time in more than five years.

The rally has left the market vulnerable to a short-term pullback of up to 3 percent in the S&P 500 as bullish sentiment continues to rise, according to Richard Ross, Auerbach Grayson's global technical strategist.

"Still," Ross said, "we have a lot of momentum and nice seasonality, and technicals support the long-term bull market."

Data on Monday pointed to growing economic momentum as companies sensed improved consumer demand.

Thomson Reuters data showed that of the 150 companies in the S&P 500 that have reported earnings so far, 67.3 percent have beaten analysts' expectations, which is a higher proportion than over the past four quarters and above the average since 1994.

The Dow Jones industrial average <.dji> fell 9.02 points or 0.06 percent, to 13,886.96, the S&P 500 <.spx> lost 1.5 points or 0.1 percent, to 1,501.46 and the Nasdaq Composite <.ixic> added 8.46 points or 0.27 percent, to 3,158.17.

Bargain hunters lifted Apple after the tech giant's stock dropped 14.4 percent in the previous two sessions. With Apple's stock up 2.4 percent at $450.29, the iPad and iPhone maker regained the title as the largest U.S. company by market capitalization as Exxon Mobil fell 0.9 percent to $90.94 and slipped back to second place.

"I think there is more downside in Apple if you did get a broad market pullback," Auerbach Grayson's Ross said.

"I'd be patient unless you're a trader. It might not be the most attractive entry point."

U.S. durable goods orders jumped 4.6 percent in December, a pace that far outstripped expectations for a rise of 1.8 percent. Pending home sales unexpectedly dropped 4.3 percent. Analysts were looking for an increase of 0.3 percent.

Equities have also gained support from a recent agreement in Washington to extend the government's borrowing power. On Monday, Fitch Ratings said that agreement removed the near-term risk to the country's 'AAA' rating.

Hess Corp shares shot up 5.3 percent to $62.02 after the company said it would exit its refining business, freeing up to $1 billion of capital. Separately, hedge fund Elliott Associates is looking for approval to buy about $800 million more in Hess stock.

Keryx Biopharmaceuticals Inc said a late-stage trial of its experimental kidney disease drug met the main study goal, and its shares soared 67 percent to $5.75.

(Editing by Jan Paschal and Nick Zieminski)

Source: http://news.yahoo.com/stock-index-futures-signal-slight-gains-104646069--finance.html

apple dividend snow white and the huntsman snow white and the huntsman rupaul drag race walking dead comic kratom broncos